GelSana Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $10M

  • Investors
  • 15

GelSana General Information

Description

Manufacturer of a wound dressing designed for chronic wound healing. The company offers a stretchable hydrogel dressing with a shelf-stable formulation, a zwitterionic polymer base, anti-inflammatory properties, bacterial attachment resistance, and moisture-balancing capability, providing healthcare providers with a tool to accelerate the healing of chronic and difficult-to-treat wounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 326
  • Aurora, CO 80045
  • United States
+1 (216)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 326
  • Aurora, CO 80045
  • United States
+1 (216)

GelSana Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GelSana Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series A) $10M Upcoming Generating Revenue
11. Seed Round 08-Oct-2026 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Accelerator/Incubator 06-Jun-2025 Completed Generating Revenue
8. Grant 10-Apr-2024 Completed Generating Revenue
7. Grant 16-Nov-2023 Completed Generating Revenue
6. Grant 21-May-2023 Completed Generating Revenue
5. Grant 24-Apr-2023 Completed Generating Revenue
4. Grant 17-Jun-2022 $260K Completed Generating Revenue
3. Grant 09-Mar-2022 $11K Completed Generating Revenue
To view GelSana’s complete valuation and funding history, request access »

GelSana Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 456,542 $0.000100 $0.39 $0.39 1x $0.39 5%
To view GelSana’s complete cap table history, request access »

GelSana Patents

GelSana Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4319819-A1 Radical crosslinked zwitterionic gels and uses thereof Pending 09-Apr-2021
EP-4319819-A4 Radical crosslinked zwitterionic gels and uses thereof Pending 09-Apr-2021
US-20220332902-A1 Radical crosslinked zwitterionic gels and uses thereof Pending 09-Apr-2021
WO-2022217069-A1 Radical crosslinked zwitterionic gels and uses thereof Inactive 09-Apr-2021 A61L26/0061

GelSana Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GelSana Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosphere Ventures Accelerator/Incubator Minority
Mines Venture Fund Venture Capital Minority
She's Independent Angel Group Minority
University of Colorado Deming Center Venture Fund Venture Capital Minority
MedTech Innovator Accelerator/Incubator
You’re viewing 5 of 15 investors. Get the full list »

GelSana FAQs

  • When was GelSana founded?

    GelSana was founded in 2020.

  • Where is GelSana headquartered?

    GelSana is headquartered in Aurora, CO.

  • What is the size of GelSana?

    GelSana has 10 total employees.

  • What industry is GelSana in?

    GelSana’s primary industry is Biotechnology.

  • Is GelSana a private or public company?

    GelSana is a Private company.

  • What is GelSana’s current revenue?

    The current revenue for GelSana is .

  • How much funding has GelSana raised over time?

    GelSana has raised $4.35M.

  • Who are GelSana’s investors?

    Innosphere Ventures, Mines Venture Fund, She's Independent, University of Colorado Deming Center Venture Fund, and MedTech Innovator are 5 of 15 investors who have invested in GelSana.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process